Format

Send to

Choose Destination
Photobiomodul Photomed Laser Surg. 2019 Jul;37(7):395-407. doi: 10.1089/photob.2019.4618. Epub 2019 Jun 17.

The Rationale for Photobiomodulation Therapy of Vaginal Tissue for Treatment of Genitourinary Syndrome of Menopause: An Analysis of Its Mechanism of Action, and Current Clinical Outcomes.

Author information

1
1 Raymond J. Lanzafame, MD PLLC, Rochester, New York.
2
2 Seattle OB/GYN Group, Seattle, Washington.
3
3 International Consultants in Aesthetic Medicine, Dallas, Texas.

Abstract

Objective: Light, particularly in the visible to far-infrared spectrum, has been applied to the female genital tract with lasers and other devices for nearly 50 years. These have included procedures on both normal and neoplastic tissues, management of condylomata, endometriosis, and menometrorrhagia, and, more recently, a number of fractional laser devices have been applied for the management of genitourinary syndrome of menopause (GSM) and stress urinary incontinence (SUI), and to achieve so-called vaginal rejuvenation. Photobiomodulation therapy (PBMT) has been proposed as an alternative for use in managing GSM and SUI. Methods: This article reviews the biological basis, symptoms, and management of GSM, and investigates the current status and rationale for the use of PBMT. Results and conclusions: Based on the preliminary evidence available, PBMT is safe and appears to be efficacious in treating GSM.

KEYWORDS:

collagen; genitourinary syndrome of menopause; photobiomodulation; stress urinary incontinence; tissue regeneration and healing; vagina; womens' health

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center